Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Hikma Pharmaceuticals in the US joined government ... to market a copycat before the expiration of patents related to the brand-name drug. Merck said in the filing that it is currently considering ...

Investing.com -- Shares of Hikma Pharmaceuticals (LON:HIK) jumped on Thursday after the company raised its full-year guidance ...

Hikma Pharmaceuticals PLC HIK shares shed 1.94% to £18.20 Tuesday, on what proved to be an all-around rough trading session ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

Glenmark Specialty SA and Hikma Pharmaceuticals PLC (Hikma). "Across our three businesses, we are driving good demand for our broad product portfolio and recent product launches," Chief Executive ...

Every pharmaceutical marketer wants their brand campaign to be more emotional, but do we know why emotional marketing is important for brand adoption? To help you answer this question, this ...

But Amneal, Hikma, and Solco say their shortages are “due to an issue with the active ingredient.” If you have a prescription for the name-brand or generic versions of Vyvanse—or any other ...

Piper Sandler has initiated coverage on ANI Pharmaceuticals (NASDAQ ... on generics to a new focus on integrating high-margin brand assets aimed at rare diseases. Cortrophin Gel ...

When the stock was hit hard in 2022, the managers felt the brand remained strong and ... In the third quarter, generic specialist Hikma Pharmaceuticals hit their screens and met their ...

When the stock was hit hard in 2022, the managers felt the brand remained strong and ... In the third quarter, generic specialist Hikma Pharmaceuticals hit their screens and met their ...